The global costs of schizophrenia.
Schizophrenia is a chronic disease associated with a significant and long-lasting health, social, and financial burden, not only for patients but also for families, other caregivers, and the wider society. Many national and local studies have sought to estimate the societal burden of the illness--or...
Päätekijät: | Knapp, M, Mangalore, R, Simon, J |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2004
|
Samankaltaisia teoksia
-
The cost of schizophrenia in Japan
Tekijä: Sado M, et al.
Julkaistu: (2013-05-01) -
The global prevalence of schizophrenia.
Tekijä: Dinesh Bhugra
Julkaistu: (2005-05-01) -
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Tekijä: Correll Christoph U, et al.
Julkaistu: (2008-04-01) -
Costs and efficacy ofolanzapine and risperidone in schizophrenia
Tekijä: Vittorio Mapelli
Julkaistu: (2007-06-01) -
The cost of relapse and the predictors of relapse in the treatment of schizophrenia
Tekijä: Slade Eric P, et al.
Julkaistu: (2010-01-01)